Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


If P&G Seeks OTC Sale, Pharma Buyers Might Line Up

Executive Summary

P&G's activist investor Trian Fund Management is known for pressuring big companies to break up. The OTC business would likely have plenty of potential buyers.

You may also be interested in...

P&G Announces 'Irresistible Superiority' Strategy To Win In Global Slump

Firm's sales were down in all segments but health care in the third quarter, reflecting challenges it sees worldwide across consumer industries. In this environment, and facing the threat of commoditization in the categories where it competes, P&G is focused on delivering "irresistible superiority," a strategy that drew questions from analysts as to how exactly it will translate to wins in practice.

P&G Portfolio Rationalization Brushes Off 20% Of Oral Care SKUs

P&G completes the bulk of the portfolio rationalization it launched in 2014, shedding or restructuring more than half of its brands globally to focus on 10 core categories, says CFO Jon Moeller.

Coty Wraps P&G Merger, Projects Return To Growth In FY 2017 Back Half

New CEO Camillo Pane says the 40-plus beauty brands picked up from P&G position Coty as a “challenger” in global beauty. The firm aims to achieve a “best-in-class profit margin and cash flow conversion model,” with projected growth acceleration in the second half of fiscal 2017.

Related Content


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts